Service & Software
Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Research Report 2026
- Mar 17, 26
- ID: 743366
- Pages: 142
- Figures: 146
- Views: 4
This report delivers a comprehensive overview of the global Drug Metabolism and Pharmacokinetics (DMPK) Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Drug Metabolism and Pharmacokinetics (DMPK) Service. The Drug Metabolism and Pharmacokinetics (DMPK) Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Drug Metabolism and Pharmacokinetics (DMPK) Service market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Drug Metabolism and Pharmacokinetics (DMPK) Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
NuChem Sciences Inc
Sygnature Discovery
Paraza Pharma, Inc
Dalriada
Inotiv
Eurofins Discovery
RTI International
Frontage Labs
Labcorp
Jubilant Biosys
Creative Biolabs
Evotec
Charles River
Anthem Bio Sciences
Molecular Diagnostic Services, Inc
Invitrocue
TCG Lifesciences Private Limited
Q 2 Solutions
WuXi AppTec
oncodesign service
Alliance Pharma, Inc
QPS Holdings
NUVISAN
Segment by Type
In Vivo Drug Metabolism and Pharmacokinetics Services
In Vitro Drug Metabolism and Pharmacokinetics Services
Segment by Application
Pharmaceutical Research and Development
Biotechnology
Efficacy Testing
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Drug Metabolism and Pharmacokinetics (DMPK) Service companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global Drug Metabolism and Pharmacokinetics (DMPK) Service market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Drug Metabolism and Pharmacokinetics (DMPK) Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
NuChem Sciences Inc
Sygnature Discovery
Paraza Pharma, Inc
Dalriada
Inotiv
Eurofins Discovery
RTI International
Frontage Labs
Labcorp
Jubilant Biosys
Creative Biolabs
Evotec
Charles River
Anthem Bio Sciences
Molecular Diagnostic Services, Inc
Invitrocue
TCG Lifesciences Private Limited
Q 2 Solutions
WuXi AppTec
oncodesign service
Alliance Pharma, Inc
QPS Holdings
NUVISAN
Segment by Type
In Vivo Drug Metabolism and Pharmacokinetics Services
In Vitro Drug Metabolism and Pharmacokinetics Services
Segment by Application
Pharmaceutical Research and Development
Biotechnology
Efficacy Testing
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Drug Metabolism and Pharmacokinetics (DMPK) Service companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 In Vivo Drug Metabolism and Pharmacokinetics Services
1.2.3 In Vitro Drug Metabolism and Pharmacokinetics Services
1.3 Market by Application
1.3.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical Research and Development
1.3.3 Biotechnology
1.3.4 Efficacy Testing
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Perspective (2021–2032)
2.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Growth Trends by Region
2.2.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Drug Metabolism and Pharmacokinetics (DMPK) Service Historic Market Size by Region (2021–2026)
2.2.3 Drug Metabolism and Pharmacokinetics (DMPK) Service Forecasted Market Size by Region (2027–2032)
2.3 Drug Metabolism and Pharmacokinetics (DMPK) Service Market Dynamics
2.3.1 Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Trends
2.3.2 Drug Metabolism and Pharmacokinetics (DMPK) Service Market Drivers
2.3.3 Drug Metabolism and Pharmacokinetics (DMPK) Service Market Challenges
2.3.4 Drug Metabolism and Pharmacokinetics (DMPK) Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Metabolism and Pharmacokinetics (DMPK) Service Players by Revenue
3.1.1 Global Top Drug Metabolism and Pharmacokinetics (DMPK) Service Players by Revenue (2021–2026)
3.1.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue Market Share by Players (2021–2026)
3.2 Global Top Drug Metabolism and Pharmacokinetics (DMPK) Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue
3.4 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Concentration Ratio
3.4.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue in 2025
3.5 Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK) Service Head Offices and Areas Served
3.6 Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK) Service, Products and Applications
3.7 Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK) Service, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Drug Metabolism and Pharmacokinetics (DMPK) Service Breakdown Data by Type
4.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Historic Market Size by Type (2021–2026)
4.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Forecasted Market Size by Type (2027–2032)
5 Drug Metabolism and Pharmacokinetics (DMPK) Service Breakdown Data by Application
5.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Historic Market Size by Application (2021–2026)
5.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size (2021–2032)
6.2 North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2021–2026)
6.4 North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size (2021–2032)
7.2 Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2021–2026)
7.4 Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size (2021–2032)
8.2 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Region (2021–2026)
8.4 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size (2021–2032)
9.2 Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2021–2026)
9.4 Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size (2021–2032)
10.2 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2021–2026)
10.4 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NuChem Sciences Inc
11.1.1 NuChem Sciences Inc Company Details
11.1.2 NuChem Sciences Inc Business Overview
11.1.3 NuChem Sciences Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.1.4 NuChem Sciences Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.1.5 NuChem Sciences Inc Recent Development
11.2 Sygnature Discovery
11.2.1 Sygnature Discovery Company Details
11.2.2 Sygnature Discovery Business Overview
11.2.3 Sygnature Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.2.4 Sygnature Discovery Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.2.5 Sygnature Discovery Recent Development
11.3 Paraza Pharma, Inc
11.3.1 Paraza Pharma, Inc Company Details
11.3.2 Paraza Pharma, Inc Business Overview
11.3.3 Paraza Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.3.4 Paraza Pharma, Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.3.5 Paraza Pharma, Inc Recent Development
11.4 Dalriada
11.4.1 Dalriada Company Details
11.4.2 Dalriada Business Overview
11.4.3 Dalriada Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.4.4 Dalriada Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.4.5 Dalriada Recent Development
11.5 Inotiv
11.5.1 Inotiv Company Details
11.5.2 Inotiv Business Overview
11.5.3 Inotiv Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.5.4 Inotiv Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.5.5 Inotiv Recent Development
11.6 Eurofins Discovery
11.6.1 Eurofins Discovery Company Details
11.6.2 Eurofins Discovery Business Overview
11.6.3 Eurofins Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.6.4 Eurofins Discovery Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.6.5 Eurofins Discovery Recent Development
11.7 RTI International
11.7.1 RTI International Company Details
11.7.2 RTI International Business Overview
11.7.3 RTI International Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.7.4 RTI International Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.7.5 RTI International Recent Development
11.8 Frontage Labs
11.8.1 Frontage Labs Company Details
11.8.2 Frontage Labs Business Overview
11.8.3 Frontage Labs Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.8.4 Frontage Labs Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.8.5 Frontage Labs Recent Development
11.9 Labcorp
11.9.1 Labcorp Company Details
11.9.2 Labcorp Business Overview
11.9.3 Labcorp Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.9.4 Labcorp Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.9.5 Labcorp Recent Development
11.10 Jubilant Biosys
11.10.1 Jubilant Biosys Company Details
11.10.2 Jubilant Biosys Business Overview
11.10.3 Jubilant Biosys Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.10.4 Jubilant Biosys Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.10.5 Jubilant Biosys Recent Development
11.11 Creative Biolabs
11.11.1 Creative Biolabs Company Details
11.11.2 Creative Biolabs Business Overview
11.11.3 Creative Biolabs Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.11.4 Creative Biolabs Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.11.5 Creative Biolabs Recent Development
11.12 Evotec
11.12.1 Evotec Company Details
11.12.2 Evotec Business Overview
11.12.3 Evotec Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.12.4 Evotec Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.12.5 Evotec Recent Development
11.13 Charles River
11.13.1 Charles River Company Details
11.13.2 Charles River Business Overview
11.13.3 Charles River Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.13.4 Charles River Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.13.5 Charles River Recent Development
11.14 Anthem Bio Sciences
11.14.1 Anthem Bio Sciences Company Details
11.14.2 Anthem Bio Sciences Business Overview
11.14.3 Anthem Bio Sciences Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.14.4 Anthem Bio Sciences Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.14.5 Anthem Bio Sciences Recent Development
11.15 Molecular Diagnostic Services, Inc
11.15.1 Molecular Diagnostic Services, Inc Company Details
11.15.2 Molecular Diagnostic Services, Inc Business Overview
11.15.3 Molecular Diagnostic Services, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.15.4 Molecular Diagnostic Services, Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.15.5 Molecular Diagnostic Services, Inc Recent Development
11.16 Invitrocue
11.16.1 Invitrocue Company Details
11.16.2 Invitrocue Business Overview
11.16.3 Invitrocue Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.16.4 Invitrocue Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.16.5 Invitrocue Recent Development
11.17 TCG Lifesciences Private Limited
11.17.1 TCG Lifesciences Private Limited Company Details
11.17.2 TCG Lifesciences Private Limited Business Overview
11.17.3 TCG Lifesciences Private Limited Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.17.4 TCG Lifesciences Private Limited Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.17.5 TCG Lifesciences Private Limited Recent Development
11.18 Q 2 Solutions
11.18.1 Q 2 Solutions Company Details
11.18.2 Q 2 Solutions Business Overview
11.18.3 Q 2 Solutions Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.18.4 Q 2 Solutions Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.18.5 Q 2 Solutions Recent Development
11.19 WuXi AppTec
11.19.1 WuXi AppTec Company Details
11.19.2 WuXi AppTec Business Overview
11.19.3 WuXi AppTec Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.19.4 WuXi AppTec Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.19.5 WuXi AppTec Recent Development
11.20 oncodesign service
11.20.1 oncodesign service Company Details
11.20.2 oncodesign service Business Overview
11.20.3 oncodesign service Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.20.4 oncodesign service Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.20.5 oncodesign service Recent Development
11.21 Alliance Pharma, Inc
11.21.1 Alliance Pharma, Inc Company Details
11.21.2 Alliance Pharma, Inc Business Overview
11.21.3 Alliance Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.21.4 Alliance Pharma, Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.21.5 Alliance Pharma, Inc Recent Development
11.22 QPS Holdings
11.22.1 QPS Holdings Company Details
11.22.2 QPS Holdings Business Overview
11.22.3 QPS Holdings Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.22.4 QPS Holdings Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.22.5 QPS Holdings Recent Development
11.23 NUVISAN
11.23.1 NUVISAN Company Details
11.23.2 NUVISAN Business Overview
11.23.3 NUVISAN Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.23.4 NUVISAN Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.23.5 NUVISAN Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 In Vivo Drug Metabolism and Pharmacokinetics Services
1.2.3 In Vitro Drug Metabolism and Pharmacokinetics Services
1.3 Market by Application
1.3.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical Research and Development
1.3.3 Biotechnology
1.3.4 Efficacy Testing
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Perspective (2021–2032)
2.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Growth Trends by Region
2.2.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Drug Metabolism and Pharmacokinetics (DMPK) Service Historic Market Size by Region (2021–2026)
2.2.3 Drug Metabolism and Pharmacokinetics (DMPK) Service Forecasted Market Size by Region (2027–2032)
2.3 Drug Metabolism and Pharmacokinetics (DMPK) Service Market Dynamics
2.3.1 Drug Metabolism and Pharmacokinetics (DMPK) Service Industry Trends
2.3.2 Drug Metabolism and Pharmacokinetics (DMPK) Service Market Drivers
2.3.3 Drug Metabolism and Pharmacokinetics (DMPK) Service Market Challenges
2.3.4 Drug Metabolism and Pharmacokinetics (DMPK) Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Metabolism and Pharmacokinetics (DMPK) Service Players by Revenue
3.1.1 Global Top Drug Metabolism and Pharmacokinetics (DMPK) Service Players by Revenue (2021–2026)
3.1.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue Market Share by Players (2021–2026)
3.2 Global Top Drug Metabolism and Pharmacokinetics (DMPK) Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue
3.4 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Concentration Ratio
3.4.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue in 2025
3.5 Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK) Service Head Offices and Areas Served
3.6 Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK) Service, Products and Applications
3.7 Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK) Service, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Drug Metabolism and Pharmacokinetics (DMPK) Service Breakdown Data by Type
4.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Historic Market Size by Type (2021–2026)
4.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Forecasted Market Size by Type (2027–2032)
5 Drug Metabolism and Pharmacokinetics (DMPK) Service Breakdown Data by Application
5.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Historic Market Size by Application (2021–2026)
5.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Service Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size (2021–2032)
6.2 North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2021–2026)
6.4 North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size (2021–2032)
7.2 Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2021–2026)
7.4 Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size (2021–2032)
8.2 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Region (2021–2026)
8.4 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size (2021–2032)
9.2 Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2021–2026)
9.4 Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size (2021–2032)
10.2 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2021–2026)
10.4 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NuChem Sciences Inc
11.1.1 NuChem Sciences Inc Company Details
11.1.2 NuChem Sciences Inc Business Overview
11.1.3 NuChem Sciences Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.1.4 NuChem Sciences Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.1.5 NuChem Sciences Inc Recent Development
11.2 Sygnature Discovery
11.2.1 Sygnature Discovery Company Details
11.2.2 Sygnature Discovery Business Overview
11.2.3 Sygnature Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.2.4 Sygnature Discovery Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.2.5 Sygnature Discovery Recent Development
11.3 Paraza Pharma, Inc
11.3.1 Paraza Pharma, Inc Company Details
11.3.2 Paraza Pharma, Inc Business Overview
11.3.3 Paraza Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.3.4 Paraza Pharma, Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.3.5 Paraza Pharma, Inc Recent Development
11.4 Dalriada
11.4.1 Dalriada Company Details
11.4.2 Dalriada Business Overview
11.4.3 Dalriada Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.4.4 Dalriada Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.4.5 Dalriada Recent Development
11.5 Inotiv
11.5.1 Inotiv Company Details
11.5.2 Inotiv Business Overview
11.5.3 Inotiv Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.5.4 Inotiv Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.5.5 Inotiv Recent Development
11.6 Eurofins Discovery
11.6.1 Eurofins Discovery Company Details
11.6.2 Eurofins Discovery Business Overview
11.6.3 Eurofins Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.6.4 Eurofins Discovery Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.6.5 Eurofins Discovery Recent Development
11.7 RTI International
11.7.1 RTI International Company Details
11.7.2 RTI International Business Overview
11.7.3 RTI International Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.7.4 RTI International Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.7.5 RTI International Recent Development
11.8 Frontage Labs
11.8.1 Frontage Labs Company Details
11.8.2 Frontage Labs Business Overview
11.8.3 Frontage Labs Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.8.4 Frontage Labs Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.8.5 Frontage Labs Recent Development
11.9 Labcorp
11.9.1 Labcorp Company Details
11.9.2 Labcorp Business Overview
11.9.3 Labcorp Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.9.4 Labcorp Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.9.5 Labcorp Recent Development
11.10 Jubilant Biosys
11.10.1 Jubilant Biosys Company Details
11.10.2 Jubilant Biosys Business Overview
11.10.3 Jubilant Biosys Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.10.4 Jubilant Biosys Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.10.5 Jubilant Biosys Recent Development
11.11 Creative Biolabs
11.11.1 Creative Biolabs Company Details
11.11.2 Creative Biolabs Business Overview
11.11.3 Creative Biolabs Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.11.4 Creative Biolabs Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.11.5 Creative Biolabs Recent Development
11.12 Evotec
11.12.1 Evotec Company Details
11.12.2 Evotec Business Overview
11.12.3 Evotec Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.12.4 Evotec Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.12.5 Evotec Recent Development
11.13 Charles River
11.13.1 Charles River Company Details
11.13.2 Charles River Business Overview
11.13.3 Charles River Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.13.4 Charles River Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.13.5 Charles River Recent Development
11.14 Anthem Bio Sciences
11.14.1 Anthem Bio Sciences Company Details
11.14.2 Anthem Bio Sciences Business Overview
11.14.3 Anthem Bio Sciences Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.14.4 Anthem Bio Sciences Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.14.5 Anthem Bio Sciences Recent Development
11.15 Molecular Diagnostic Services, Inc
11.15.1 Molecular Diagnostic Services, Inc Company Details
11.15.2 Molecular Diagnostic Services, Inc Business Overview
11.15.3 Molecular Diagnostic Services, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.15.4 Molecular Diagnostic Services, Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.15.5 Molecular Diagnostic Services, Inc Recent Development
11.16 Invitrocue
11.16.1 Invitrocue Company Details
11.16.2 Invitrocue Business Overview
11.16.3 Invitrocue Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.16.4 Invitrocue Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.16.5 Invitrocue Recent Development
11.17 TCG Lifesciences Private Limited
11.17.1 TCG Lifesciences Private Limited Company Details
11.17.2 TCG Lifesciences Private Limited Business Overview
11.17.3 TCG Lifesciences Private Limited Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.17.4 TCG Lifesciences Private Limited Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.17.5 TCG Lifesciences Private Limited Recent Development
11.18 Q 2 Solutions
11.18.1 Q 2 Solutions Company Details
11.18.2 Q 2 Solutions Business Overview
11.18.3 Q 2 Solutions Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.18.4 Q 2 Solutions Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.18.5 Q 2 Solutions Recent Development
11.19 WuXi AppTec
11.19.1 WuXi AppTec Company Details
11.19.2 WuXi AppTec Business Overview
11.19.3 WuXi AppTec Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.19.4 WuXi AppTec Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.19.5 WuXi AppTec Recent Development
11.20 oncodesign service
11.20.1 oncodesign service Company Details
11.20.2 oncodesign service Business Overview
11.20.3 oncodesign service Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.20.4 oncodesign service Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.20.5 oncodesign service Recent Development
11.21 Alliance Pharma, Inc
11.21.1 Alliance Pharma, Inc Company Details
11.21.2 Alliance Pharma, Inc Business Overview
11.21.3 Alliance Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.21.4 Alliance Pharma, Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.21.5 Alliance Pharma, Inc Recent Development
11.22 QPS Holdings
11.22.1 QPS Holdings Company Details
11.22.2 QPS Holdings Business Overview
11.22.3 QPS Holdings Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.22.4 QPS Holdings Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.22.5 QPS Holdings Recent Development
11.23 NUVISAN
11.23.1 NUVISAN Company Details
11.23.2 NUVISAN Business Overview
11.23.3 NUVISAN Drug Metabolism and Pharmacokinetics (DMPK) Service Introduction
11.23.4 NUVISAN Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
11.23.5 NUVISAN Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of In Vivo Drug Metabolism and Pharmacokinetics Services
Table 3. Key Players of In Vitro Drug Metabolism and Pharmacokinetics Services
Table 4. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Region (US$ Million), 2021–2026
Table 7. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Region (2021–2026)
Table 8. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Region (2027–2032)
Table 10. Drug Metabolism and Pharmacokinetics (DMPK) Service Market Trends
Table 11. Drug Metabolism and Pharmacokinetics (DMPK) Service Market Drivers
Table 12. Drug Metabolism and Pharmacokinetics (DMPK) Service Market Challenges
Table 13. Drug Metabolism and Pharmacokinetics (DMPK) Service Market Restraints
Table 14. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue by Players (US$ Million), 2021–2026
Table 15. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Players (2021–2026)
Table 16. Global Top Drug Metabolism and Pharmacokinetics (DMPK) Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue, 2025
Table 17. Ranking of Global Top Drug Metabolism and Pharmacokinetics (DMPK) Service Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK) Service, Headquarters and Area Served
Table 20. Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK) Service, Products and Applications
Table 21. Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK) Service, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Type (US$ Million), 2021–2026
Table 24. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue Market Share by Type (2021–2026)
Table 25. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue Market Share by Type (2027–2032)
Table 27. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Application (US$ Million), 2021–2026
Table 28. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue Market Share by Application (2021–2026)
Table 29. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue Market Share by Application (2027–2032)
Table 31. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (US$ Million), 2021–2026
Table 33. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (US$ Million), 2027–2032
Table 46. NuChem Sciences Inc Company Details
Table 47. NuChem Sciences Inc Business Overview
Table 48. NuChem Sciences Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 49. NuChem Sciences Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 50. NuChem Sciences Inc Recent Development
Table 51. Sygnature Discovery Company Details
Table 52. Sygnature Discovery Business Overview
Table 53. Sygnature Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 54. Sygnature Discovery Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 55. Sygnature Discovery Recent Development
Table 56. Paraza Pharma, Inc Company Details
Table 57. Paraza Pharma, Inc Business Overview
Table 58. Paraza Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 59. Paraza Pharma, Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 60. Paraza Pharma, Inc Recent Development
Table 61. Dalriada Company Details
Table 62. Dalriada Business Overview
Table 63. Dalriada Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 64. Dalriada Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 65. Dalriada Recent Development
Table 66. Inotiv Company Details
Table 67. Inotiv Business Overview
Table 68. Inotiv Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 69. Inotiv Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 70. Inotiv Recent Development
Table 71. Eurofins Discovery Company Details
Table 72. Eurofins Discovery Business Overview
Table 73. Eurofins Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 74. Eurofins Discovery Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 75. Eurofins Discovery Recent Development
Table 76. RTI International Company Details
Table 77. RTI International Business Overview
Table 78. RTI International Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 79. RTI International Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 80. RTI International Recent Development
Table 81. Frontage Labs Company Details
Table 82. Frontage Labs Business Overview
Table 83. Frontage Labs Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 84. Frontage Labs Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 85. Frontage Labs Recent Development
Table 86. Labcorp Company Details
Table 87. Labcorp Business Overview
Table 88. Labcorp Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 89. Labcorp Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 90. Labcorp Recent Development
Table 91. Jubilant Biosys Company Details
Table 92. Jubilant Biosys Business Overview
Table 93. Jubilant Biosys Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 94. Jubilant Biosys Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 95. Jubilant Biosys Recent Development
Table 96. Creative Biolabs Company Details
Table 97. Creative Biolabs Business Overview
Table 98. Creative Biolabs Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 99. Creative Biolabs Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 100. Creative Biolabs Recent Development
Table 101. Evotec Company Details
Table 102. Evotec Business Overview
Table 103. Evotec Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 104. Evotec Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 105. Evotec Recent Development
Table 106. Charles River Company Details
Table 107. Charles River Business Overview
Table 108. Charles River Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 109. Charles River Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 110. Charles River Recent Development
Table 111. Anthem Bio Sciences Company Details
Table 112. Anthem Bio Sciences Business Overview
Table 113. Anthem Bio Sciences Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 114. Anthem Bio Sciences Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 115. Anthem Bio Sciences Recent Development
Table 116. Molecular Diagnostic Services, Inc Company Details
Table 117. Molecular Diagnostic Services, Inc Business Overview
Table 118. Molecular Diagnostic Services, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 119. Molecular Diagnostic Services, Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 120. Molecular Diagnostic Services, Inc Recent Development
Table 121. Invitrocue Company Details
Table 122. Invitrocue Business Overview
Table 123. Invitrocue Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 124. Invitrocue Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 125. Invitrocue Recent Development
Table 126. TCG Lifesciences Private Limited Company Details
Table 127. TCG Lifesciences Private Limited Business Overview
Table 128. TCG Lifesciences Private Limited Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 129. TCG Lifesciences Private Limited Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 130. TCG Lifesciences Private Limited Recent Development
Table 131. Q 2 Solutions Company Details
Table 132. Q 2 Solutions Business Overview
Table 133. Q 2 Solutions Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 134. Q 2 Solutions Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 135. Q 2 Solutions Recent Development
Table 136. WuXi AppTec Company Details
Table 137. WuXi AppTec Business Overview
Table 138. WuXi AppTec Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 139. WuXi AppTec Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 140. WuXi AppTec Recent Development
Table 141. oncodesign service Company Details
Table 142. oncodesign service Business Overview
Table 143. oncodesign service Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 144. oncodesign service Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 145. oncodesign service Recent Development
Table 146. Alliance Pharma, Inc Company Details
Table 147. Alliance Pharma, Inc Business Overview
Table 148. Alliance Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 149. Alliance Pharma, Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 150. Alliance Pharma, Inc Recent Development
Table 151. QPS Holdings Company Details
Table 152. QPS Holdings Business Overview
Table 153. QPS Holdings Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 154. QPS Holdings Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 155. QPS Holdings Recent Development
Table 156. NUVISAN Company Details
Table 157. NUVISAN Business Overview
Table 158. NUVISAN Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 159. NUVISAN Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 160. NUVISAN Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
Table 164. Authors List of This Report
List of Figures
Figure 1. Drug Metabolism and Pharmacokinetics (DMPK) Service Picture
Figure 2. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Type: 2025 vs 2032
Figure 4. In Vivo Drug Metabolism and Pharmacokinetics Services Features
Figure 5. In Vitro Drug Metabolism and Pharmacokinetics Services Features
Figure 6. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Application: 2025 vs 2032
Figure 8. Pharmaceutical Research and Development Case Studies
Figure 9. Biotechnology Case Studies
Figure 10. Efficacy Testing Case Studies
Figure 11. Others Case Studies
Figure 12. Drug Metabolism and Pharmacokinetics (DMPK) Service Report Years Considered
Figure 13. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Region: 2025 vs 2032
Figure 16. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Players in 2025
Figure 17. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue in 2025
Figure 19. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country (2021–2032)
Figure 21. United States Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country (2021–2032)
Figure 25. Germany Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Region (2021–2032)
Figure 33. China Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country (2021–2032)
Figure 41. Mexico Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country (2021–2032)
Figure 45. Israel Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. NuChem Sciences Inc Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 49. Sygnature Discovery Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 50. Paraza Pharma, Inc Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 51. Dalriada Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 52. Inotiv Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 53. Eurofins Discovery Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 54. RTI International Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 55. Frontage Labs Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 56. Labcorp Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 57. Jubilant Biosys Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 58. Creative Biolabs Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 59. Evotec Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 60. Charles River Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 61. Anthem Bio Sciences Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 62. Molecular Diagnostic Services, Inc Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 63. Invitrocue Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 64. TCG Lifesciences Private Limited Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 65. Q 2 Solutions Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 66. WuXi AppTec Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 67. oncodesign service Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 68. Alliance Pharma, Inc Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 69. QPS Holdings Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 70. NUVISAN Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Table 1. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of In Vivo Drug Metabolism and Pharmacokinetics Services
Table 3. Key Players of In Vitro Drug Metabolism and Pharmacokinetics Services
Table 4. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Region (US$ Million), 2021–2026
Table 7. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Region (2021–2026)
Table 8. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Region (2027–2032)
Table 10. Drug Metabolism and Pharmacokinetics (DMPK) Service Market Trends
Table 11. Drug Metabolism and Pharmacokinetics (DMPK) Service Market Drivers
Table 12. Drug Metabolism and Pharmacokinetics (DMPK) Service Market Challenges
Table 13. Drug Metabolism and Pharmacokinetics (DMPK) Service Market Restraints
Table 14. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue by Players (US$ Million), 2021–2026
Table 15. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Players (2021–2026)
Table 16. Global Top Drug Metabolism and Pharmacokinetics (DMPK) Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue, 2025
Table 17. Ranking of Global Top Drug Metabolism and Pharmacokinetics (DMPK) Service Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK) Service, Headquarters and Area Served
Table 20. Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK) Service, Products and Applications
Table 21. Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK) Service, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Type (US$ Million), 2021–2026
Table 24. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue Market Share by Type (2021–2026)
Table 25. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue Market Share by Type (2027–2032)
Table 27. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Application (US$ Million), 2021–2026
Table 28. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue Market Share by Application (2021–2026)
Table 29. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue Market Share by Application (2027–2032)
Table 31. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (US$ Million), 2021–2026
Table 33. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Country (US$ Million), 2027–2032
Table 46. NuChem Sciences Inc Company Details
Table 47. NuChem Sciences Inc Business Overview
Table 48. NuChem Sciences Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 49. NuChem Sciences Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 50. NuChem Sciences Inc Recent Development
Table 51. Sygnature Discovery Company Details
Table 52. Sygnature Discovery Business Overview
Table 53. Sygnature Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 54. Sygnature Discovery Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 55. Sygnature Discovery Recent Development
Table 56. Paraza Pharma, Inc Company Details
Table 57. Paraza Pharma, Inc Business Overview
Table 58. Paraza Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 59. Paraza Pharma, Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 60. Paraza Pharma, Inc Recent Development
Table 61. Dalriada Company Details
Table 62. Dalriada Business Overview
Table 63. Dalriada Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 64. Dalriada Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 65. Dalriada Recent Development
Table 66. Inotiv Company Details
Table 67. Inotiv Business Overview
Table 68. Inotiv Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 69. Inotiv Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 70. Inotiv Recent Development
Table 71. Eurofins Discovery Company Details
Table 72. Eurofins Discovery Business Overview
Table 73. Eurofins Discovery Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 74. Eurofins Discovery Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 75. Eurofins Discovery Recent Development
Table 76. RTI International Company Details
Table 77. RTI International Business Overview
Table 78. RTI International Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 79. RTI International Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 80. RTI International Recent Development
Table 81. Frontage Labs Company Details
Table 82. Frontage Labs Business Overview
Table 83. Frontage Labs Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 84. Frontage Labs Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 85. Frontage Labs Recent Development
Table 86. Labcorp Company Details
Table 87. Labcorp Business Overview
Table 88. Labcorp Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 89. Labcorp Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 90. Labcorp Recent Development
Table 91. Jubilant Biosys Company Details
Table 92. Jubilant Biosys Business Overview
Table 93. Jubilant Biosys Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 94. Jubilant Biosys Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 95. Jubilant Biosys Recent Development
Table 96. Creative Biolabs Company Details
Table 97. Creative Biolabs Business Overview
Table 98. Creative Biolabs Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 99. Creative Biolabs Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 100. Creative Biolabs Recent Development
Table 101. Evotec Company Details
Table 102. Evotec Business Overview
Table 103. Evotec Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 104. Evotec Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 105. Evotec Recent Development
Table 106. Charles River Company Details
Table 107. Charles River Business Overview
Table 108. Charles River Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 109. Charles River Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 110. Charles River Recent Development
Table 111. Anthem Bio Sciences Company Details
Table 112. Anthem Bio Sciences Business Overview
Table 113. Anthem Bio Sciences Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 114. Anthem Bio Sciences Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 115. Anthem Bio Sciences Recent Development
Table 116. Molecular Diagnostic Services, Inc Company Details
Table 117. Molecular Diagnostic Services, Inc Business Overview
Table 118. Molecular Diagnostic Services, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 119. Molecular Diagnostic Services, Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 120. Molecular Diagnostic Services, Inc Recent Development
Table 121. Invitrocue Company Details
Table 122. Invitrocue Business Overview
Table 123. Invitrocue Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 124. Invitrocue Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 125. Invitrocue Recent Development
Table 126. TCG Lifesciences Private Limited Company Details
Table 127. TCG Lifesciences Private Limited Business Overview
Table 128. TCG Lifesciences Private Limited Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 129. TCG Lifesciences Private Limited Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 130. TCG Lifesciences Private Limited Recent Development
Table 131. Q 2 Solutions Company Details
Table 132. Q 2 Solutions Business Overview
Table 133. Q 2 Solutions Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 134. Q 2 Solutions Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 135. Q 2 Solutions Recent Development
Table 136. WuXi AppTec Company Details
Table 137. WuXi AppTec Business Overview
Table 138. WuXi AppTec Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 139. WuXi AppTec Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 140. WuXi AppTec Recent Development
Table 141. oncodesign service Company Details
Table 142. oncodesign service Business Overview
Table 143. oncodesign service Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 144. oncodesign service Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 145. oncodesign service Recent Development
Table 146. Alliance Pharma, Inc Company Details
Table 147. Alliance Pharma, Inc Business Overview
Table 148. Alliance Pharma, Inc Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 149. Alliance Pharma, Inc Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 150. Alliance Pharma, Inc Recent Development
Table 151. QPS Holdings Company Details
Table 152. QPS Holdings Business Overview
Table 153. QPS Holdings Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 154. QPS Holdings Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 155. QPS Holdings Recent Development
Table 156. NUVISAN Company Details
Table 157. NUVISAN Business Overview
Table 158. NUVISAN Drug Metabolism and Pharmacokinetics (DMPK) Service Product
Table 159. NUVISAN Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (US$ Million), 2021–2026
Table 160. NUVISAN Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
Table 164. Authors List of This Report
List of Figures
Figure 1. Drug Metabolism and Pharmacokinetics (DMPK) Service Picture
Figure 2. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Type: 2025 vs 2032
Figure 4. In Vivo Drug Metabolism and Pharmacokinetics Services Features
Figure 5. In Vitro Drug Metabolism and Pharmacokinetics Services Features
Figure 6. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Application: 2025 vs 2032
Figure 8. Pharmaceutical Research and Development Case Studies
Figure 9. Biotechnology Case Studies
Figure 10. Efficacy Testing Case Studies
Figure 11. Others Case Studies
Figure 12. Drug Metabolism and Pharmacokinetics (DMPK) Service Report Years Considered
Figure 13. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Region: 2025 vs 2032
Figure 16. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Players in 2025
Figure 17. Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Drug Metabolism and Pharmacokinetics (DMPK) Service Revenue in 2025
Figure 19. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country (2021–2032)
Figure 21. United States Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country (2021–2032)
Figure 25. Germany Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Region (2021–2032)
Figure 33. China Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country (2021–2032)
Figure 41. Mexico Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Service Market Share by Country (2021–2032)
Figure 45. Israel Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Drug Metabolism and Pharmacokinetics (DMPK) Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. NuChem Sciences Inc Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 49. Sygnature Discovery Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 50. Paraza Pharma, Inc Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 51. Dalriada Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 52. Inotiv Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 53. Eurofins Discovery Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 54. RTI International Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 55. Frontage Labs Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 56. Labcorp Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 57. Jubilant Biosys Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 58. Creative Biolabs Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 59. Evotec Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 60. Charles River Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 61. Anthem Bio Sciences Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 62. Molecular Diagnostic Services, Inc Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 63. Invitrocue Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 64. TCG Lifesciences Private Limited Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 65. Q 2 Solutions Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 66. WuXi AppTec Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 67. oncodesign service Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 68. Alliance Pharma, Inc Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 69. QPS Holdings Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 70. NUVISAN Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Service Business (2021–2026)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232